Agata Sasor

Lund, M, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

ARHGAP4 as a Prognostic Biomarker for Colon Liver Metastases After Surgical Resection.

ARHGAP4 as a Prognostic Biomarker for Colon Liver Metastases After Surgical Resection.

Journal: Anticancer research

Published: March 05, 2024

Histopathological investigation of colon liver metastases - which factors affect survival after surgery?

Histopathological investigation of colon liver metastases - which factors affect survival after surgery?

Journal: Scandinavian journal of gastroenterology

Published: November 28, 2022

Expression of peritumoral SPARC during distal cholangiocarcinoma progression and correlation with outcome.

Expression of peritumoral SPARC during distal cholangiocarcinoma progression and correlation with outcome.

Journal: Scandinavian journal of gastroenterology

Published: June 17, 2020

Mass spectrometry-based analysis of formalin-fixed, paraffin-embedded distal cholangiocarcinoma identifies stromal thrombospondin-2 as a potential prognostic marker.

Mass spectrometry-based analysis of formalin-fixed, paraffin-embedded distal cholangiocarcinoma identifies stromal thrombospondin-2 as a potential prognostic marker.

Journal: Journal of translational medicine

Published: April 18, 2020

Echinococcus multilocularis infection - six cases during two years in Sweden

Echinococcus multilocularis infection - six cases during two years in Sweden

Journal: Lakartidningen

Published: February 12, 2020

Expression of fibroblast activation protein and the clinicopathological relevance in distal cholangiocarcinoma.

Expression of fibroblast activation protein and the clinicopathological relevance in distal cholangiocarcinoma.

Journal: Scandinavian journal of gastroenterology

Published: January 10, 2020

YAP1 is an independent prognostic marker in pancreatic cancer and associated with extracellular matrix remodeling.

YAP1 is an independent prognostic marker in pancreatic cancer and associated with extracellular matrix remodeling.

Journal: Journal of translational medicine

Published: September 10, 2019

Low P4HA2 and high PRTN3 expression predicts poor survival in patients with pancreatic cancer.

Low P4HA2 and high PRTN3 expression predicts poor survival in patients with pancreatic cancer.

Journal: Scandinavian journal of gastroenterology

Published: March 19, 2019

Quantitative proteomics identifies brain acid soluble protein 1 (BASP1) as a prognostic biomarker candidate in pancreatic cancer tissue.

Quantitative proteomics identifies brain acid soluble protein 1 (BASP1) as a prognostic biomarker candidate in pancreatic cancer tissue.

Journal: EBioMedicine

Published: March 05, 2019

Galectin 4 is a biomarker for early recurrence and death after surgical resection for pancreatic ductal adenocarcinoma.

Galectin 4 is a biomarker for early recurrence and death after surgical resection for pancreatic ductal adenocarcinoma.

Journal: Scandinavian journal of gastroenterology

Published: January 22, 2019

Alpha-1-acid glycoprotein 1 is upregulated in pancreatic ductal adenocarcinoma and confers a poor prognosis.

Alpha-1-acid glycoprotein 1 is upregulated in pancreatic ductal adenocarcinoma and confers a poor prognosis.

Journal: Translational research : the journal of laboratory and clinical medicine

Published: January 20, 2019

Stromal fibronectin expression in patients with resected pancreatic ductal adenocarcinoma.

Stromal fibronectin expression in patients with resected pancreatic ductal adenocarcinoma.

Journal: World journal of surgical oncology

Published: October 05, 2018

Showing 1-12 of 28

Last Updated: 09/26/2026